Search results
Recce Pharmaceuticals granted China patent for RECCE® Anti-Infectives
Proactive Investors· 9 hours agoRecce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has completed its portfolio of wholly-owned Family 2...
Recce Pharmaceuticals completes global patent portfolio
Proactive Investors· 6 hours agoRecce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) CEO James Graham joins Proactive’s Jonathan Jackson...
Fisher Asset Management LLC Purchases 108 Shares of Vertex Pharmaceuticals Incorporated...
ETF DAILY NEWS· 5 hours agoFisher Asset Management LLC raised its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 0.4% during the 4th quarter, according to the company ...
Kiniksa Pharmaceuticals Ltd (KNSA) gets rating Reiterated from BofA Securities – Knox Daily
Knox Daily· 6 days agoKiniksa Pharmaceuticals Ltd’s recently made public that its CHAIRMAN & CEO Patel Sanj K unloaded Company’s shares for reported $1.37 million on Mar 07 ’ ...
Sciwind Biosciences and HK inno.N Corporation Announce Licensing and Partnership Agreement for...
WFRV 5 Green Bay· 4 hours agoSciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation, a South Korean ...
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Holdings Cut by Russell Investments Group Ltd.
ETF DAILY NEWS· 6 days agoRussell Investments Group Ltd. lowered its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 84.5% during the fourth quarter, according ...
Jazz Pharmaceuticals (NASDAQ:JAZZ) Receives “Buy” Rating from Needham & Company LLC
ETF DAILY NEWS· 1 day agoNeedham & Company LLC reiterated their buy rating on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) in a report released on Thursday morning, Benzinga reports.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Sold by Swiss National Bank
ETF DAILY NEWS· 1 day agoSwiss National Bank trimmed its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 2.4% during the fourth quarter, according to the company in its most ...
abrdn plc Makes New Investment in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
ETF DAILY NEWS· 6 days agoabrdn plc purchased a new stake in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) during the 4th quarter, according to the company in its most recent filing with ...
Phathom Pharmaceuticals (NASDAQ:PHAT) Receives New Coverage from Analysts at Stifel Nicolaus
ETF DAILY NEWS· 1 day agoStifel Nicolaus initiated coverage on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a report issued on Friday, MarketBeat.com reports. The firm issued a ...